Breast Cancer
📧 Sign up to get email alerts when something new happens for Breast Cancer.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Lapatinib in Metastatic Breast Cancer Resistant to Hormone Therapy [Phase 2]
This clinical trial update reports Phase 2 results for lapatinib in metastatic breast cancer resistant to hormone therapy, with the study te…
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: Magnetic Resonance Imaging in Women Recently Diagnosed With Unilateral Breast Cancer [NA]
Clinical trial update on MRI use in women recently diagnosed with unilateral breast cancer; study completed with results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-07-27Clinical Trial Update: ImmunoTEP au 68-Ga- IMP-288 for Patients With a Recurrence of HER2 Negative Breast Carcinoma Expressing CEA [Phase 1, Phase 2]
Completed Phase 1/2 trial evaluating ImmunoTEP 68Ga-IMP-288 in patients with recurrent HER2-negative breast cancer expressing CEA.
-
CLINICAL_TRIALS research · 2018-07-26Clinical Trial Update: A Study of the Addition of Metronomic Capecitabine to Standard Adjuvant Therapy in High Risk HER2+ BC paTients [Phase 3]
A Phase 3 clinical trial is evaluating the addition of metronomic capecitabine to standard adjuvant therapy for high-risk HER2-positive brea…
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: Neo-adjuvant Therapy With Anastrozole Plus Pazopanib in Stage II and III ER+ Breast Cancer [Phase 2]
A phase 2 neoadjuvant trial of anastrozole plus pazopanib in stage II/III estrogen receptor-positive, HER2-negative breast cancer was termin…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-07-26Clinical Trial Update: GSM (Genitourinary Syndrome Of Menopause) Management In Breast Cancer Survivors [EARLY_Phase 1]
An early Phase 1 trial evaluating genitourinary syndrome of menopause management in breast cancer survivors was terminated.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Study to Validate a Model of Surgical Deescalation in Atypicals Breast Lesions [NA]
A clinical trial evaluating a model for de-escalating surgery in atypical breast lesions has completed.
-
CLINICAL_TRIALS trial_result · 2018-07-24Clinical Trial Update: Docetaxel With or Without a Phytochemical in Treating Patients With Breast Cancer [Phase 2]
A Phase 2 trial evaluating docetaxel with or without an unnamed phytochemical in breast cancer has been terminated.
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: Tolerance of PICC Line Versus Implanted Port for Adjuvant Chemotherapy in Early Breast Cancer [Phase 2]
This Phase 2 clinical trial update compares the tolerance of a PICC line versus an implanted port for adjuvant chemotherapy in patients with…
-
CLINICAL_TRIALS research · 2018-07-24Clinical Trial Update: The IMPETUS Cancer Trial. A Technology Delivered Physical Activity Intervention in Cancer [NA]
An update on the IMPETUS Cancer Trial, a technology-delivered physical activity intervention for cancer, enrolling in breast and colorectal …
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: A Study of Pertuzumab and Trastuzumab Subcutaneous (SC) Treatment in Combination With a Taxane in Participants With Human Epidermal Growth Factor Receptor 2 (HER2)-Positive Metastatic Breast Cancer [Phase 3]
Phase 3 trial evaluating pertuzumab and trastuzumab subcutaneous in combination with a taxane for HER2-positive metastatic breast cancer has…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: MUC1 Vaccine for Triple-negative Breast Cancer [EARLY_Phase 1]
An early-phase Phase 1 trial evaluating a MUC1 vaccine for breast cancer has completed its evaluation. The study targets inflammatory breast…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: MK2206 in Combination With Anastrozole, Fulvestrant, or Anastrozole and Fulvestrant in Treating Postmenopausal Women With Metastatic Breast Cancer [Phase 1]
Phase 1 trial evaluating MK-2206 in combination with anastrozole and/or fulvestrant in postmenopausal women with metastatic breast cancer; s…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Prospective Observational Study of Febrile Neutropenia (FN) and Pegfilgrastim Primary Prophylaxis in Breast Cancer and Non-Hodgkin's Lymphoma Patients Receiving High (>20%) FN-risk Chemotherapy
This completed prospective observational study evaluated febrile neutropenia and pegfilgrastim primary prophylaxis in breast cancer and Non-…
-
CLINICAL_TRIALS trial_result · 2018-07-23Clinical Trial Update: Fulvestrant in Metastatic Breast Cancer [Phase 4]
An update on a Phase 4 trial evaluating fulvestrant in metastatic breast cancer. The current trial status is unknown.
-
CLINICAL_TRIALS research · 2018-07-23Clinical Trial Update: Influence of Multidisciplinary Breast Tumor Board on Physician Decision
A clinical trial update examining how a multidisciplinary breast tumor board influences physicians' treatment decisions in breast cancer car…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: An Open Label, Phase II Trial of Continuous Low-Irradiance Photodynamic Therapy (CLIPT) Using Verteporfin (Visudyne®) for the Treatment of Cutaneous Metastases of Breast Cancer [Phase 2]
Open-label Phase II trial evaluating continuous low-irradiance photodynamic therapy with Verteporfin (Visudyne) for cutaneous metastases of …
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Phase I/IIa Trial of Gemcitabine Plus Trastuzumab and Pertuzumab in Previously Treated Metastatic HER2+ Breast Cancer [Phase 1, Phase 2]
Phase I/IIa trial exploring gemcitabine with trastuzumab and pertuzumab in previously treated metastatic HER2-positive breast cancer has com…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Evaluation of the NantHealth GPS Cancer Test in Patients With Advanced Cancers
This clinical trial update notes the termination of the study evaluating the NantHealth GPS Cancer Test in patients with advanced cancers. T…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Effects of Granulocyte Colony-stimulating Factor (G-CSF), Trastuzumab, and Vinorelbine on Immune Cell Function [Phase 2, Phase 3]
A Phase 2/3 trial evaluated the effects of combining granulocyte colony-stimulating factor (G-CSF), trastuzumab, and vinorelbine on immune c…
-
CLINICAL_TRIALS trial_result · 2018-07-20Clinical Trial Update: Single Dose Ablative Radiation Treatment for Early-Stage Breast Cancer [NA]
Clinical trial update reporting completion of a study evaluating a single-dose ablative radiation treatment for early-stage breast cancer, s…
-
FDA approval · 2018-07-20FDA Approved: GEMCITABINE — Original Application (Sagent Pharmaceuticals)
FDA approves Sagent Pharmaceuticals' original ANDA for gemcitabine, a generic injectable chemotherapy used to treat several cancers.
-
CLINICAL_TRIALS trial_result · 2018-07-19Clinical Trial Update: Web-Base App To Improve Aromatase Inhibitor Adherence [NA]
Completed clinical trial evaluating a web-based app designed to improve adherence to aromatase inhibitors in women with breast cancer.
-
CLINICAL_TRIALS research · 2018-07-19Clinical Trial Update: Radiomics of Mp-MRI Assessing NAC Outcome in Breast Cancer
This ClinicalTrials.gov update describes a study using multiparametric MRI radiomics to assess responses to neoadjuvant chemotherapy in brea…
-
CLINICAL_TRIALS trial_result · 2018-07-18Clinical Trial Update: Diagnostic Outcomes Of The Females Presenting With Breast Lump In Surgical Department Services Hospital Lahore
A completed clinical trial from Services Hospital Lahore evaluated the diagnostic outcomes for women presenting with a breast lump in the su…